Why the study?
VIV TAVR can restrict flow, especially in small native aortic valves, prompting the use of bioprosthetic valve fracture to increase effective orifice area and improve hemodynamics.
Does bioprosthetic valve fracture improve hemodynamics in high surgical risk patients undergoing VIV TAVR?
Does bioprosthetic valve fracture improve hemodynamics in high surgical risk patients undergoing VIV TAVR?
Answers are grounded in this paper and cite their sources.
Bioprosthetic valve fracture is a viable technique to increase the effective orifice area and improve hemodynamics during VIV TAVR, particularly in patients with small native valves.
Valve-in-valve transcatheter aortic valve replacement (VIV TAVR) has emerged as a preferable option for high surgical risk patients requiring redo aortic valve replacement. However, VIV TAVR may restrict flow, especially in small native aortic valves. To remedy this, bioprosthetic valve fracture has been utilized to increase the effective orifice area and improve hemodynamics. We present three cases in which bioprosthetic valve fracture was used to increase hemodynamic flow in VIV TAVR procedures.
No takes yet. Share an insight, caveat, or question.
James et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: